Anas Barbarie Hepatis Et Cordis Extractum
Prescription商品名: Flu Immune
About This Medication
Oral preparation used for symptom management and health support.
有効成分
| 成分 | 含有量 |
|---|---|
| Cairina Moschata Heart/Liver Autolysate | - |
適応症と用法
用量と投与方法
警告と注意事項
WARNINGS: • If symptoms persist or worsen, seek advice of licensed health care practitioner. • If pregnant or nursing, take on only advice of licensed heatlh care practitioner. • Keep this and all medications out of reach of children. • Keep this and all medications out of reach of children.
Frequently Asked Questions
INDICATIONS FOR USE: For the temporary relief of flu-related symptoms such as aches, pains, fever and chills. Flu Immune can be used at the onset of flu-like symptoms and as preventative. Flu Immune helps stimulate the body's immunity and is reccommended as first line of defense against flu-like symptoms. **
DIRECTIONS: Spray 9-12 pumps (approximately 1/2 tsp.) directly in mouth 3 times a day or as directed by licensed health care practitioner. When appropriate, also spray externally on complaint area 3 times daily.
WARNINGS: • If symptoms persist or worsen, seek advice of licensed health care practitioner. • If pregnant or nursing, take on only advice of licensed heatlh care practitioner. • Keep this and all medications out of reach of children. • Keep this and all medications out of reach of children.
Anas Barbarie Hepatis Et Cordis Extractum is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Tablet Products
Browse all Tablet products →References & Data Sources
- • DailyMed — Anas Barbarie Hepatis Et Cordis Extractum drug label (National Library of Medicine)
- • openFDA — Anas Barbarie Hepatis Et Cordis Extractum label data (U.S. Food & Drug Administration)
- • NDC Directory — Anas Barbarie Hepatis Et Cordis Extractum (FDA National Drug Code)
医療免責事項
このページの情報は教育目的のみを意図しており、専門家による医療アドバイス、診断、または治療の代替として使用すべきではありません。
疾患や医薬品に関するご質問がある場合は、必ず担当医またはその他の資格を持つ医療専門家にご相談ください。
データソース: DailyMed (NLM), openFDA, MFDS